MENU
VACBF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
NYKODE THERAPEUTICS AS (VACBF) Ownership - Who owns NYKODE THERAPEUTICS AS?
Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies... Show more
Profile
Industry
N/A
Address
Gaustadalleen 21
Phone
+47 22958193
Employees
155
Web
https://www.nykode.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
54.56M
P/E Ratio
N/A
Total Cash
69.99M
Projected Growth
N/A
Total Debt
3.1M
Revenue
7.31M
Risk (Beta)
N/A
Dividend Yield
0.50
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
VACBF
Capitalization
54.6M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
0.50
Total Cash
70M
Total Cash/Share
0.21
Total Debt
3.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
7.31M
ROE
N/A
Book Value
103M
P/B Ratio
0.64
Cash Flow
N/A
Earnings
-0.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
367K
Current Ratio
15.21
Current Revenue Per Employee
48726.62
Dividends Per Share - Security
0.10
EBITDA
-21.96M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-11.71
Shares Held By Institutions
33.5M
Shares Outstanding - Current
327M
Total Liabilities
8.84M
Total Volume MTD
N/A
Value
1
Gain YTD
-16.944
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Gaustadalleen 21
Phone
+47 22958193
Employees
155
Web
https://www.nykode.com